1986
DOI: 10.1016/s0168-8227(86)80068-7
|View full text |Cite
|
Sign up to set email alerts
|

Immunogenicity of biosynthetic human insulin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1989
1989
2001
2001

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…The investigators observed a gradual decrease in circulating anti‐insulin antibodies detectable over the course of 3 months, indicating a reduced immunoreactivity of the recombinant protein. A more extensive study 2 assessed the immunogenicity of rh‐insulin in diabetic patients who had never received insulin treatment and in diabetic patients who had already been treated with monocomponent (single animal species) insulin. In both studies, responses to rh‐insulin were compared with matched control groups receiving other forms of insulin treatment.…”
Section: Hormonesmentioning
confidence: 99%
“…The investigators observed a gradual decrease in circulating anti‐insulin antibodies detectable over the course of 3 months, indicating a reduced immunoreactivity of the recombinant protein. A more extensive study 2 assessed the immunogenicity of rh‐insulin in diabetic patients who had never received insulin treatment and in diabetic patients who had already been treated with monocomponent (single animal species) insulin. In both studies, responses to rh‐insulin were compared with matched control groups receiving other forms of insulin treatment.…”
Section: Hormonesmentioning
confidence: 99%